Evidence map›Paper›PMID 23078142›Full record

ArticleMolecular microbiology2012

A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans.

Emma J Griffiths, Guanggan Hu, Bettina Fries, Mélissa Caza, Joyce Wang, Joerg Gsponer, Marcellene A Gates-Hollingsworth, Thomas R Kozel, Louis De Repentigny, James W Kronstad

Abstract read
In one paragraph

Article in Molecular microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. A Limited Number of Amino Acid Permeases Are Crucial forInternational journal of microbiology · 2024
    Review
  7. The Response ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Plant physiology · 2019
    Article
  12. Editorial: Cellular and Molecular Mechanisms ofFrontiers in cellular and infection microbiology · 2019
    Article
  13. Article
  14. CitE Enzymes Are Essential forFrontiers in cellular and infection microbiology · 2018
    Article
  15. Article
  16. Physiological Differences in Cryptococcus neoformans StrainsAntimicrobial agents and chemotherapy · 2017
    Review
  17. Microevolutionary traits and comparative population genomics of the emerging pathogenic fungus Cryptococcus gattii.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Emma J GriffithsThe Michael Smith Laboratories, Department of Microbiology and Immunology, Faculty of Land and Food Systems, University of British Columbia, Vancouver, BC, Canada, V6T 1Z4.
Guanggan Hu
Bettina Fries
Mélissa Caza
Joyce Wang
Joerg Gsponer
Marcellene A Gates-Hollingsworth
Thomas R Kozel
Louis De Repentigny
James W Kronstad
Canada's Michael Smith Genome Sciences Centre · CAUniversity of British Columbia · CAUniversity of Nevada, Reno · USAlbert Einstein College of Medicine · USUniversité de Montréal · CA

Funding

Comparative and functional genomics of C. neoformansR01AI053721 · NIAID · UNIVERSITY OF BRITISH COLUMBIA · PI KRONSTAD, JAMES W · 2003 to 2024
$5.4M
response to phenotypic switch variants to C. neoformansR01AI059681 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2004 to 2014
$3.6M
Cryptococcal polysaccharide-phagocytosis inhibitionR01AI014209 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 1985 to 2009
$1.9M
CIHR MOP-93597NIAID NIH HHS R01 AI014209NIAID NIH HHS R01 AI053721NIAID NIH HHS R01 AI059681
6 · The paper itself

Abstract

The interaction of Cryptococcus neoformans with phagocytic cells of the innate immune system is a key step in disseminated disease leading to meningoencephalitis in immunocompromised individuals. Transcriptional profiling of cryptococcal cells harvested from cell culture medium or from macrophages found differential expression of metabolic and other functions during fungal adaptation to the intracellular environment. We focused on the ACL1 gene for ATP-citrate lyase, which converts citrate to acetyl-CoA, because this gene showed elevated transcript levels in macrophages and because of the importance of acetyl-CoA as a central metabolite. Mutants lacking ACL1 showed delayed growth on medium containing glucose, reduced cellular levels of acetyl-CoA, defective production of virulence factors, increased susceptibility to the antifungal drug fluconazole and decreased survival within macrophages. Importantly, acl1 mutants were unable to cause disease in a murine inhalation model, a phenotype that was more extreme than other mutants with defects in acetyl-CoA production (e.g. an acetyl-CoA synthetase mutant). Loss of virulence is likely due to perturbation of critical physiological interconnections between virulence factor expression and metabolism in C. neoformans. Phylogenetic analysis and structural modelling of cryptococcal Acl1 identified three indels unique to fungal protein sequences; these differences may provide opportunities for the development of pathogen-specific inhibitors.

Indexed as

Acetyl Coenzyme AAmino Acid SequenceAnimalsATP Citrate (pro-S)-LyaseCell LineCitric AcidCryptococcosisCryptococcus neoformansCulture MediaDisease Models, AnimalGlucoseINDEL MutationMacrophagesMiceMicrobial ViabilityModels, MolecularAcetyl Coenzyme AATP Citrate (pro-S)-LyaseCitric AcidCulture MediaGlucoseVirulence Factors

Identifiers

PMID23078142
PMCPMC3524413
OpenAlexW1889047264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.